Cardioplegia Solution Recalled for Lack of Sterility Assurance
Central Admixture Pharmacy Services, Inc. is recalling 48 bags of Cardioplegia Solution after an FDA inspection found the manufacturer could not assure the product's sterility. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The product is a risk-of-harm item (sterile injectable medication) where injury has not yet been reported, consistent with the High severity category per the rubric.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Cardioplegia Solution, Induction 8:1 High Potassium/Low Dextrose (100 mEq K, 500 mL per bag) with NDC 71285-0107-1. The recall involves 48 bags from two lots: Lot # 37-897926 (Expiration 05/13/2023) and Lot # 37-900464 (Expiration 05/22/2023).
The FDA recalled the product after an inspection called into question the sterility of the product. Cardioplegia solution is an injectable medication used in cardiac surgery to stop the heart during the procedure. Without proper assurance of sterility, the product poses a contamination risk.
The product was distributed nationwide in the United States to hospitals and healthcare facilities.
Healthcare providers should not use these lots.
The recalled product
- Product
- Cardioplegia Solution, Induction 8:1 High Potassium/low dextrose, 100 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0107-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Cardioplegia Solution
- Hazard
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 37-897926
- Exp 05/13/2023
- 37-900464
- Exp 05/22/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27